AXPH logo

Alexandria Co. For Pharmaceuticals & Chemical Industries Stock Price

CASE:AXPH Community·ج.م4.0b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 4 Fair Values set on narratives written by author

AXPH Share Price Performance

ج.م800.37
390.04 (95.06%)
ج.م800.37
390.04 (95.06%)
Price ج.م800.37

AXPH Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with solid track record and pays a dividend.

3 Risks
2 Rewards

Alexandria Co. For Pharmaceuticals & Chemical Industries Key Details

ج.م3.0b

Revenue

ج.م2.3b

Cost of Revenue

ج.م767.0m

Gross Profit

ج.م273.0m

Other Expenses

ج.م494.0m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
98.81
25.40%
16.36%
0.4%
View Full Analysis

About AXPH

Founded
1962
Employees
n/a
CEO
Mahmoud Rizk
WebsiteView website
www.alexcopharma.net

Alexandria Co. For Pharmaceuticals & Chemical Industries operates as a pharmaceutical company in Egypt. The company manufactures, markets, and distributes branded generics of human and animal health products. It also provides human products, such as tablets, syrups, suppositories, drops, ampoule, and crème; medical appliances; and Veterinary Products. In addition, the company offers antibiotics and anesthetics, ophthalmic, cardiovascular, gastrointestinal, genitourinary, and respiratory drugs. Alexandria Co. For Pharmaceuticals & Chemical Industries was founded in 1962 and is based in Alexandria, Egypt.

Recent AXPH News & Updates

Recent updates

No updates

Alexandria Co. For Pharmaceuticals & Chemical Industries Competitors